MarketInOut Stock Screener Log In | Sign Up
 

Biodesix Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
Biodesix Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization252.59 mln
Float4.69 mln
Earnings Date11/05/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.69
Likely reliable

1-Year Forecast

39.00
Transformational upside

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

7.85
Extremely leveraged

Pre-Tax Margin

-27%
Deeply loss-making

Business Description

Biodesix is a medical diagnostics company based in Louisville, Colorado, focused on helping doctors detect and manage lung cancer through blood-based testing. Its key products help identify whether lung nodules are likely to be cancerous and guide treatment decisions by analyzing tumor mutations and immune system activity. The company also supports pharmaceutical and life sciences firms with services ranging from early biomarker research through to clinical trial testing and regulatory assistance. Founded in 2005, Biodesix operates its own laboratories and has built its business around making lung cancer diagnosis faster and more precise.

Key Fundamentals

EPS-3.10
ROE-912
RPS11.59
ROIC-31.74
ROA-30.43
Interest Cover-2.54
EBITDA, mln-14.06
EV / EBITDA-24.94
EV / EBIT-17.83
Revenue, mln103
EV / Revenue3.41

Quote Details

Last 21.18
Change -2.76 (-11.53%)
Open 23.66
Volume 139,273
Turnover 2,949,802
Average Volume 100,823

Financial Ratios

Pre-Tax Profit Margin-27
Leverage Ratio10.42
Current Ratio2.85
Price / Book34.29
Debt / Equity7.85
Price / Sales2.57

Financial Strength

Altman Z-Score-4.64
Piotroski F-Score 5 / 9
Beneish M-Score-2.69
1-Year Target Price39.00
Short Ratio2.26
Short % of Float3.31

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.48% 8 / 100   
1 Month -27.96% 13 / 100   
2 Months 6.92% 84 / 100   
6 Months 99.06% 98 / 100   
1 Year 253% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog